JP2023507399A - 6-カルボキシベンゾオキサゾール誘導体を作製するための効率的なプロセス - Google Patents

6-カルボキシベンゾオキサゾール誘導体を作製するための効率的なプロセス Download PDF

Info

Publication number
JP2023507399A
JP2023507399A JP2022537301A JP2022537301A JP2023507399A JP 2023507399 A JP2023507399 A JP 2023507399A JP 2022537301 A JP2022537301 A JP 2022537301A JP 2022537301 A JP2022537301 A JP 2022537301A JP 2023507399 A JP2023507399 A JP 2023507399A
Authority
JP
Japan
Prior art keywords
compound
formula
dichlorophenyl
acid
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022537301A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507399A5 (https=
Inventor
ピーター カラン サイモン
メアリー オニール パドレイ
Original Assignee
ファイザー アイルランド ファーマシューティカルズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー アイルランド ファーマシューティカルズ filed Critical ファイザー アイルランド ファーマシューティカルズ
Publication of JP2023507399A publication Critical patent/JP2023507399A/ja
Publication of JP2023507399A5 publication Critical patent/JP2023507399A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2022537301A 2019-12-20 2020-12-16 6-カルボキシベンゾオキサゾール誘導体を作製するための効率的なプロセス Pending JP2023507399A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962951691P 2019-12-20 2019-12-20
US62/951,691 2019-12-20
US202063120426P 2020-12-02 2020-12-02
US63/120,426 2020-12-02
PCT/IB2020/062040 WO2021124158A1 (en) 2019-12-20 2020-12-16 Efficient process for making 6-carboxy benzoxazole derivatives

Publications (2)

Publication Number Publication Date
JP2023507399A true JP2023507399A (ja) 2023-02-22
JP2023507399A5 JP2023507399A5 (https=) 2023-12-12

Family

ID=73856234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022537301A Pending JP2023507399A (ja) 2019-12-20 2020-12-16 6-カルボキシベンゾオキサゾール誘導体を作製するための効率的なプロセス

Country Status (14)

Country Link
US (1) US12410145B2 (https=)
EP (1) EP4077287B1 (https=)
JP (1) JP2023507399A (https=)
KR (1) KR20220114626A (https=)
CN (1) CN115135639B (https=)
AU (1) AU2020406455B2 (https=)
BR (1) BR112022012097A2 (https=)
CA (1) CA3165298A1 (https=)
ES (1) ES3055912T3 (https=)
HR (1) HRP20251570T1 (https=)
IL (1) IL294115A (https=)
MX (1) MX2022007787A (https=)
TW (1) TWI771827B (https=)
WO (1) WO2021124158A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4077287B1 (en) 2019-12-20 2025-11-19 Pfizer Ireland Pharmaceuticals Unlimited Company Efficient process for making 6-carboxy benzoxazole derivatives
KR102657823B1 (ko) * 2022-03-10 2024-04-16 고려대학교 산학협력단 타파미디스의 신규 합성법
US11970468B1 (en) 2023-10-23 2024-04-30 King Faisal University 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63301884A (ja) * 1987-02-20 1988-12-08 ザ ウエルカム フアウンデーション リミテッド 有害生物防除化合物
JP2006511612A (ja) * 2002-12-19 2006-04-06 ザ スクリップス リサーチ インスティテュート トランスチレチンの安定化及びトランスチレチンの誤った折り畳みの阻害のための組成物及び方法
WO2012132796A1 (ja) * 2011-03-25 2012-10-04 Jnc株式会社 オルトエステル誘導体、液晶組成物および液晶表示素子
WO2013168014A1 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of familial amyloid polyneuropathy
JP2019514959A (ja) * 2016-05-05 2019-06-06 クリスタル ファーマテック カンパニー、リミテッドCrystal Pharmatech Co., Ltd. タファミジスメグルミン塩の結晶形e及びその製造方法並びに用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5222642A (en) 1975-08-14 1977-02-21 Kawasaki Heavy Ind Ltd Power generation device by hot water
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
JP5419545B2 (ja) 2009-05-25 2014-02-19 株式会社トクヤマ オルトエステル化合物の製造方法
US8168683B2 (en) 2009-10-15 2012-05-01 E. I. Du Pont De Nemours And Company Fluorinated vinylidene cationic surfactant
RU2586330C2 (ru) * 2011-09-16 2016-06-10 Пфайзер Инк. Твердые формы ингибитора диссоциации транстиретина
PT4349406T (pt) * 2014-09-08 2026-02-04 Pfizer Formas sólidas cristalinas de 6-carboxi-2-(3,5-diclorofenil)-benzoxazol para utilização como medicamento
US10766893B2 (en) * 2017-12-20 2020-09-08 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
EP4077287B1 (en) 2019-12-20 2025-11-19 Pfizer Ireland Pharmaceuticals Unlimited Company Efficient process for making 6-carboxy benzoxazole derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63301884A (ja) * 1987-02-20 1988-12-08 ザ ウエルカム フアウンデーション リミテッド 有害生物防除化合物
JP2006511612A (ja) * 2002-12-19 2006-04-06 ザ スクリップス リサーチ インスティテュート トランスチレチンの安定化及びトランスチレチンの誤った折り畳みの阻害のための組成物及び方法
WO2012132796A1 (ja) * 2011-03-25 2012-10-04 Jnc株式会社 オルトエステル誘導体、液晶組成物および液晶表示素子
WO2013168014A1 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of familial amyloid polyneuropathy
JP2019514959A (ja) * 2016-05-05 2019-06-06 クリスタル ファーマテック カンパニー、リミテッドCrystal Pharmatech Co., Ltd. タファミジスメグルミン塩の結晶形e及びその製造方法並びに用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GULLUZAR BASTUG ET AL.: "Functionalized Orthoesters as Powerful Building Blocks for the Efficient Preparation ofHeteroaromati", ORGANIC LETTERS, vol. 14, no. 13, JPN6024053142, 26 June 2012 (2012-06-26), pages 3502 - 3505, ISSN: 0005633692 *

Also Published As

Publication number Publication date
ES3055912T3 (en) 2026-02-16
AU2020406455B2 (en) 2024-02-15
TW202136222A (zh) 2021-10-01
EP4077287A1 (en) 2022-10-26
BR112022012097A2 (pt) 2022-08-30
CN115135639A (zh) 2022-09-30
US20230090609A1 (en) 2023-03-23
EP4077287C0 (en) 2025-11-19
HRP20251570T1 (hr) 2026-01-30
WO2021124158A1 (en) 2021-06-24
EP4077287B1 (en) 2025-11-19
MX2022007787A (es) 2022-07-19
US12410145B2 (en) 2025-09-09
KR20220114626A (ko) 2022-08-17
TWI771827B (zh) 2022-07-21
IL294115A (en) 2022-08-01
CN115135639B (zh) 2025-04-01
AU2020406455A1 (en) 2022-07-14
CA3165298A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
HU225294B1 (en) Oxazoline derivatives for synthesis of sidechain-bearing taxanes and preparation thereof
JP2023507399A (ja) 6-カルボキシベンゾオキサゾール誘導体を作製するための効率的なプロセス
AU2009208107A1 (en) A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
CA3123170C (en) PROCESS FOR THE PRODUCTION OF (5S)-4-[5-(3,5-DICHLOROPHENYL)-5-(TRIFLUOROMETHYL)-4H-ISOXAZOL-3-YL]-2-METHYLBENZOIC ACID
KR20080020613A (ko) (치환된) (r)- 또는 (s)-만델산의 동적 분할 방법
RU2810493C1 (ru) Эффективный процесс получения производных 6-карбоксибензоксазола
RU2182908C2 (ru) Стереоизомерные индольные соединения, способ их получения и их использование
RU2470018C2 (ru) Новые производные пирокатехина
HK40075510A (en) Efficient process for making 6-carboxy benzoxazole derivatives
EP0713865B1 (fr) Dérivés d'acide 2-aminobenzènesulfonique et de chlorure de 2-aminobenzènesulfonyle, leur préparation et leur utilisation comme intermédiaires de synthèse
JP4437012B2 (ja) ムスコンのアセタール付加体、その調製方法、並びに(±)−ムスコンの光学分割方法
CA2165043C (en) Process for the preparation of the enantiomers of 2-(2-fluoro-4-biphenyl)propionic acid
JPWO2012157504A1 (ja) β−ラクタム化合物およびその製造方法
RU2809762C2 (ru) Способ для получения (5s)-4-[5-(3,5-дихлорфенил)-5-(трифторметил)-4h-изоксазол-3-ил]-2-метил-бензойной кислоты
KR102060318B1 (ko) 신규의 중간체, 이의 제조방법, 및 이를 이용한 로수바스타틴 칼슘염의 제조방법
JP4070608B2 (ja) 光学的に活性なジヒドロピロンの製造方法
CZ568590A3 (cs) Deriváty kyseliny glutarové, způsob jejich přípravy a meziprodukt tohoto postupu
JPH08231469A (ja) シクロペンタンカルボン酸誘導体及びその製造法
JPS6363546B2 (https=)
HU179944B (hu) Javított eljárás 2-/di- és triszubsztituált-fenil/-glicinek előállítására
JPH0414114B2 (https=)
JPH0422900B2 (https=)
JPH0344358A (ja) 光学活性アミノ化合物とその製法
JPS6330898B2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231204

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231204

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250107

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250702